Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Selecta Biosciences (NQ: SELB )

1.230 -0.070 (-5.38%)
Streaming Delayed Price Updated: 12:49 PM EDT, Jun 29, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 657,779
Open 1.270
Bid (Size) 1.230 (243)
Ask (Size) 1.240 (27)
Prev. Close 1.300
Today's Range 1.220 - 1.270
52wk Range 0.6469 - 4.700
Shares Outstanding 115,079,292
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning! It's time to start off another busy day of trading with a look at the biggest pre-market stock movers for Wednesday! 
Via InvestorPlace
Expert Ratings for Selecta Biosciences
Over the past 3 months, 4 analysts have published their opinion on Selecta Biosciences (NASDAQ:SELB) stock. These analysts are typically employed by large Wall Street banks and tasked with... 
Via Benzinga

Performance

YTD
-62.84%
-62.84%
1 Month
+39.42%
+39.42%
3 Month
-8.89%
-8.89%
6 Month
-63.39%
-63.39%
1 Year
-72.42%
-72.42%

More News

Read More
44 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
SVB Leerink Sees Over 600% Upside For This Penny Biotech Stock
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Earnings Scheduled For March 10, 2022
Via Benzinga
63 Biggest Movers From Yesterday
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
91 Biggest Movers From Friday
Via Benzinga
24 Stocks Moving in Thursday's Pre-Market Session
Via Benzinga
7 Cheap Biotech Stocks to Buy Now
Via InvestorPlace
Executives Buy Around $1.5M Of 4 Penny Stocks
Via Benzinga
Needham Maintains Buy Rating for Selecta Biosciences: Here's What You Need To Know
Via Benzinga
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
Via Benzinga
Earnings Outlook For Selecta Biosciences
Via Benzinga
How To Attend Selecta Biosciences Q1 2022 Earnings Conference Call
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
The Daily Biotech Pulse: Pfizer Goes Shopping, AstraZeneca Inks Bispecific Antibody Deal, Aptinyx Faces Clinical Study Setback, Erytech Jumps On Data And More
Via Benzinga
Selecta Biosciences's Return On Capital Employed Insights
Via Benzinga
Selecta Biosciences: Q4 Earnings Insights
Via Benzinga
Earnings Preview: Selecta Biosciences
Via Benzinga
The Daily Biotech Pulse: Pfizer Begins Late-Stage Pediatric COVID Pill Study, Midatech And J&J Unit Expand R&D Collaboration, AbbVie-Alvotech Settle Humira Dispute
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.